Inventor

DWEK RAYMOND A

GB60 patents

⚠️ This page may combine multiple inventors who share the name “DWEK RAYMOND A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DWEK RAYMOND A

MONSANTO CO

Method of inhibiting glycolipid synthesis

Method for producing synthetic N-linked glycoconjugates

Method for treatment of CNS-involved lysosomal storage diseases

Method of inhibiting glycolipid synthesis

Deoxygalactonojirimycin derivatives

Method of treating Tay-Sachs disease

Deoxygalactonojirimycin derivatives

Method of inhibiting glycolipid synthesis

Deoxygalactonojirimycin derivatives

Method of treating cholera

Method for producing synthetic N-linked glycoconjugates

Use of oligosaccharides for treatment of arthritis

Method of inhibiting virus

Diagnostic method for diseases having an arthritic component

Compound, N-butyl-deoxynojirimycin-6-phosphate

Phosphorylated glycosidase inhibitor prodrugs

Method of inhibiting the surface expression of glycolipid receptors for bacteria

Method of treating herpesviruses

Tissue plasminogen activator from normal human colon cells

Method for carbohydrate engineering of glycoproteins

Oligosaccharide sequencing

Isolation of unreduced oligosaccharides

Isolation of unreduced oligosaccharides

Tissue plasminogen activator oligosaccharide from normal human colon cells

Method of inhibiting virus

Tissue plasminogen activator from normal human colon cells

Immunosuppressive glycoprotein

Method of inhibiting virus

Method of inhibiting virus

SEARLE & CO

Combination drug therapy for glycolipid storage diseases

Method for treatment of glycolipid storage diseases

Combination drug therapy for glycolipid storage diseases

Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy

Method of inhibiting hepatitis B virus

UNITED THERAPEUTICS CORP

Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapy

Iminosugars and methods of treating viral diseases

Iminosugars and methods of treating togaviral diseases

RAMSTEDT URBAN

Iminosugars and methods of treating bunyaviral and togaviral diseases

Iminosugars and methods of treating viral diseases

UNIV OXFORD

Inhibition of glycolipid biosynthesis

CHANCELLOR MASTERS & SCHOLARS

Inhibition of glycolipid biosynthesis

(unassigned)

Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infections

SYNERGY PHARMACEUTICALS INC

Inhibition of membrane-associated viral replication

UNIV JEFFERSON

Long chain n-alkyl compounds and oxa-derivatives thereof

ZITZMANN NICOLE

Long chain N-alkyl compounds and oxa-derivatives thereof

ACTELION PHARMACEUTICALS LTD

Therapeutic compositions and methods of treating glycolipid storage related disorders

GANGADHARAN BEVIN

Clinical diagnosis of hepatic fibrosis using a novel panel of human serum protein biomarkers

BUTTERS TERRY D

Deoxynojirimycin and D-arabinitol analogs and methods of using

UNIV OXFORD INNOVATION LTD

Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

SHOX SCIENCE LTD

Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers